HF
TIL icon

HRT Financial’s Instil Bio TIL Stock Holding History

HRT Financial’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,902
Closed -$733K – 3237
2024
Q3 		$733K Buy
+10,902
New +$257K ﹤0.01% 1404
2023
Q2 		– Sell
-3,542
Closed -$46K – 3275
2023
Q1 		$46K Sell
3,542
-5,836
-62% -$86.3K ﹤0.01% 2131
2022
Q4 		$118K Buy
+9,378
New +$463K ﹤0.01% 2037

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HRT Financial's TIL Position: Q4 2024 in Review

HRT Financial sold out of Instil Bio (TIL) in Q4 2024, closing a stake of 10,902 shares — an estimated $733K sold.

HRT Financial first reported a position in TIL in Q4 2022 and held it in 3 quarters. The position peaked at $733K in Q3 2024. 40 funds tracked by Wall St. Rank hold TIL as of Q4 2024.

  • HRT Financial reported no remaining Instil Bio position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 10,902 Instil Bio shares in Q4 2024, an estimated $733K.
  • HRT Financial first reported a position in Instil Bio in Q4 2022 and held it in 3 quarters.
  • HRT Financial's Instil Bio position peaked at $733K in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Instil Bio as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.